AARC 2018 Corporate Partners
Corporate Partner Program is comprised of best-in-class organizations interested in supporting the goals and work of the Association. The program aims to give respiratory care providers information, insights, and innovative approaches to improve performance and advance the health of their patients. Together, this move will strengthen each of us in all of our endeavors. It is with great pride that we present our Corporate Partners.
Vyaire Medical, Inc. designs, manufactures and markets capital and consumable medical devices used by healthcare professionals worldwide for respiratory diagnostics, ventilation, and anesthesia delivery & patient monitoring. The company and its 5,000 employees work toward a shared purpose of “supporting and improving the lives of patients with a laser-focus on improving patient outcomes and increasing value for customers.”
Masimo, innovator and leader of motion and low perfusion tolerant pulse oximetry, a technology that non invasively measures arterial oxygen saturation, is committed to improving patient outcomes and reducing cost of care by working with dedicated hospital staff to convert health care institutions around the world to Masimo SET pulse oximetry technology. They are accomplishing this goal by directly marketing complete pulse oximetry solutions to hospitals, as well as by partnering with patient monitoring companies to create innovative, cost-effective acquisition programs for Masimo SET products. Masimo Corporation is located in Irvine, California.
Medtronic, a global leader in medical technology, is contributing to human welfare by application of biomedical engineering in the research, design, manufacture, and sale of instruments or appliances that alleviate pain, restore health, and extend life. Medtronic is redefining how technology is used in the management of chronic disease. A deep understanding of human physiology yields unique insight into a range of therapeutic areas, including heart and vascular diseases, diabetes, neurological disorders, and spinal conditions. This breadth of offerings, combined with years of experience, allows Medtronic to deliver therapies that are transforming the treatment of chronic disease and changing the lives of more than 7 million patients worldwide each year.
Monaghan Medical Corporation (MMC) is a leader in the development and manufacture of aerosol drug delivery devices and asthma management products. Monaghan is a supplier to major pharmaceutical companies in respiratory medicine in the United States. The company’s strength lies in product development around core capabilities in mechanical design complimented by collaboration with a state-of-the-art aerosol research laboratory. Monaghan is focused on developing cost-efficient, outcome-based solutions for our customers.
Monaghan is dedicated to the pursuit of respiratory airway solutions for care providers and patients. Over 300 peer-reviewed articles supporting the company’s respiratory management products have been published in medical journals throughout the world.
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified Health and Well-being company, focused on improving people’s lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of “sense and simplicity”. Headquartered in the Netherlands, Philips employs approximately 128,000 employees in more than 60 countries worldwide. With sales of USD 42 billion (€27 billion) in 2007, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in flat TV, male shaving and grooming, portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter.
Dräger is an international leader in the fields of medical and safety technology. Our products protect, support and save lives. Founded in 1889, Dräger generated revenues of around EUR 2.6 billion in 2015. The Dräger Group is currently present in more than 190 countries and has more than 13,000 employees worldwide. Please visit www.draeger.com for more information.
Since 1838, Getinge has stood for innovation and advancement in medical technologies and is a leading provider of acute care ventilators for critical care use. Getinge SERVO ventilators are known worldwide for optimal performance, reliability, and adaptability. The platform offers all conventional modes of ventilation, capnography, and the revolutionary NAVA® technology (Neurally Adjusted Ventilatory Assist) that allows the patient and ventilator to work in synchronous harmony.
Teleflex believes in improving the health and quality of people’s lives. We apply purpose driven innovation—a relentless pursuit of identifying unmet clinical needs—in a way that benefits patients, providers and society. Our Arrow®, Hudson RCI®, LMA® and Rusch® Brands shape our portfolio of proven medical products and technologies. These distinguished brands are united by their common sense of purpose in providing anesthesia and respiratory solutions that build, nurture and strengthen the vital parts at the heart of healthcare.
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 44,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine. Follow us on Twitter at http://twitter.com/boehringerus.
AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca-us.com.
Mallinckrodt is a global specialty biopharmaceutical business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. A key product within the company’s Specialty Brands segment is INOMAX®, which is offered through the INOMAX Total Care® package, an all-inclusive offering of drug, drug-delivery system, on-site training, emergency deliveries and 24/7/365 technical assistance and support. To learn more, visit www.inomax.com.
ResMed changes lives by developing, manufacturing and distributing medical equipment for treating, diagnosing, and managing sleep-disordered breathing, chronic obstructive pulmonary disease, and other chronic diseases. We develop innovative products and solutions to improve the health and quality of life of those who suffer from these conditions, and we work to raise awareness of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit www.resmed.com.
Our products and systems are sold in over 120 countries worldwide. We sell our products through direct sales offices operations in most of our major markets, and a network of distributors that sell to hospitals, homecare providers and other manufacturers of medical devices.
Fisher & Paykel entered the respiratory care market in 1971 with the development of a unique respiratory humidifier system for use in critical care. We now offer a broad range of products and systems for use in respiratory and acute care and in the treatment of obstructive sleep apnea (OSA). For more information, visit fphcare.com.
Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. Sunovion’s vision is to lead the way to a healthier world. The company’s spirit of innovation is driven by the conviction that scientific excellence paired with meaningful advocacy and relevant education can improve lives. With patients at the center of everything it does, Sunovion has charted new paths to life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with psychiatric, neurological and respiratory conditions. For more information visit www.sunovion.us